Skip to main content
. 2019 Jun 27;11(7):1464. doi: 10.3390/nu11071464

Table 3.

Nonexclusive listing of studies on the effects of citrus flavanones on host parameters related to barrier function and inflammation.

Model [Ref.] Treatment Treatment Duration Dose and Administration Change in Main Outcomes vs. Control (Relevant Concentrations)
Caco-2 cell monolayers [73] Hesperetin vs. control
Naringenin vs. control
24 h 100 µM Barrier function:  TEER, occludin expression, claudin-4 expression, cytoskeletal association of occludin and claudin-1, and -3
FITC–dextran flux
Barrier function: TEER, occludin expression, claudin-4 expression, cytoskeletal association of ZO-2, occludin and claudin-1, -3, and -4
FITC–dextran flux
Caco-2 cell monolayers [74] Naringenin vs. control 48 h 10, 30, 100 µM Barrier function: TEER (30, 100 µM)†, claudin-4 expression (30, 100 µM)†, cytoskeletal association of occludin, claudin-1, claudin-4 and ZO-2 (100 µM)
FITC–dextran flux (30, 100 µM)†
DSS-induced colitis in male BALB/c mice [76] Naringenin vs. control diet 9 days 0.3% of the diet, oral administration Barrier function: Colonic permeability, claudin-1 expression
Occludin, junctional adhesion molecule-A, claudin-3 expression
Inflammation: DAI, colonic shortening, expression of cytokines (IFN-ϒ, IL-6, MIP-2, and IL-17A)
DSS-induced colitis in male BALB/c mice [77] Naringenin vs. control diet
Hesperetin vs. control diet
12 days 0.3% of the diet, oral administration
0.3% of the diet, oral administration
Barrier function:  Colonic permeability
  Occludin expression
Inflammation: Weight loss, colonic damage
Colon length
Barrier function: Colonic permeability, occludin expression
Inflammation: Weight loss, colonic damage
Colon length
DSS-induced colitis in male BALB/c mice [78] Hesperidin vs. control 7 days 10, 40, 80 mg/kg, oral administration Inflammation:   DAI, MPO, MDA, IL-6, colonic wet weight (10, 40, 80 mg/kg)†
Mucosal cell damage (80 mg/kg)
IL-4 (10, 40, 80 mg/kg)
TNBS-induced colitis in female Wistar rats [79] Hesperidin vs. control Twice (48 h pre- + 48 h post-colitis induction) 2.5, 5, 10, 25, 50 mg/kg, oral administration Inflammation: Colonic damage, colonic weight, colonic MPO (10, 25 mg/kg)
Glutathione levels (10, 25 mg/kg), colonic fluid absorption (10–50 mg/kg)
MDA, LTB4 (2.5–50 mg/kg)
TNBS- induced colitis in male Wistar rats [80] Orange juice vs. control
Grapefruit juice vs. control
Combination vs. control
15 days 2 mL/kg, 5 mL/kg, 8 mL/kg, oral administration
0.1 mL/kg, 0.3 mL/kg, 0.5 mL/kg, oral administration
2 mL/kg OJ + 0.1 mL/kg GJ (low dose), 5 mL/kg OJ + 0.3 mL/kg GJ (high dose), oral administration
Inflammation:   Colonic damage (2, 5, 8 mL/kg), MPO, CRP (5, 8 mL/kg), ALP (8 mg/kg)
GSH (8 mL/kg)
Inflammation:  Colonic damage (0.1, 0.3, 0.5 mL/kg) MPO, CRP (0.3, 0.5 mL/kg), ALP (0.3, 0.5 mL/kg)
GSH (0.3 mL/kg)
Inflammation:   Colonic damage, MPO, CRP, ALP (low dose, high dose)
GSH (high dose)
DNBS- induced colitis in Male CD1 mice [81] Bergamot juice extract vs. control 4 days 5, 10, 20 mg/kg, oral administration Inflammation:   Colonic damage, weight loss, MPO, TNF-α, IL-1β, ICAM-1, p-selectin, nitrotyrosine, PAR, nuclear NF-kB translocation, p-JNK activation (20 mg/kg)
Colon length (20 mg/kg)
LPS-challenged broiler chickens [82] Hesperidin vs. control diet 42 days 20 mg/kg diet, oral administration Inflammation: Phagocytic index, villus length, villus width, villus length/crypt depth
Crypt depth
Body weight gain, feed intake feed conversion ratio
Human subjects with features of metabolic syndrome [68] Citrus extract (>80% hesperidin-2S and <4% of naringin) vs. placebo 12 weeks 500 mg, oral administration Inflammation: Calprotectin

TEER, transepithelial electrical resistance. FITC, fluorescein isothiocyanate. ZO-2, zonula occludens 2. DSS, dextran sulfate sodium. DAI, disease activity index. IFN-ϒ, interferon-ϒ. IL, interleukin. MIP-2, macrophage inflammatory protein-2. MPO, myeloperoxidase. MDA, malondialdehyde. TNBS, trinitrobenzene sulfonic acid. LBT4, leukotriene B4. OJ, orange juice. GJ, grapefruit juice. CRP, C-reactive protein. ALP, alkaline phosphatase. GSH, glutathione. DNBS, dinitrobenzene sulfonic acid. TNF-α, tumor necrosis factor-α. ICAM-1, intercellular adhesion molecule-1. PAR, poly ADP-ribose. NF-kB, nuclear factor-kB. , increase. , decrease. , no significant change. †, dose-dependent effect.